11beta-HSD1 inhibitors (Pfizer)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Name11beta-HSD1 inhibitors (Pfizer)

Drug Alias Name11beta-hydroxysteroid dehydrogenase-1 inhibitors (Pfizer)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors

Targets11-beta-hydroxysteroid dehydrogenase

Therapy Area/IndicationsObesityDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsObesityDiabetes Mellitus

ATC CodeN/A